Stay updated with breaking news from Mitsui. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SINGAPORE: Japan's Mitsui & Co said on Thursday (Apr 4) it had teamed up with Rohto Pharmaceutical Co to buy Eu Yan Sang International in a deal valuing the Singapore-based traditional Chinese medicines firm at S$800 million (US$594 million). Mitsui said in a statement that a special purpose company jo
Japan's Mitsui & Co said on Thursday it had teamed up with Rohto Pharmaceutical Co to buy Eu Yan Sang International.
Tokyo stocks opened higher on Thursday after US tech shares gained in mixed Wall Street trade. The benchmark Nikkei 225 index was up 1.24 percent, or 489.25 points, at 39,941.10 in early trade, while the broader Topix index added 0.90 percent, or 24.31 points, to 2,730.82. ..
Mitsui & Co., Ltd. has decided to acquire shares in Eu Yan Sang International Ltd jointly with ROHTO Pharmaceutical Co., Ltd. and others. Based in Singapore, EYS manufactures and...
Japan's Mitsui & Co said on Thursday it had teamed up with Rohto Pharmaceutical Co to buy Eu Yan Sang International in a deal valuing the Singapore-based traditional Chinese medicines firm at S$800 million ($594 million). Mitsui said in a statement that a special purpose company jointly owned by Mitsui and Rohto would acquire around 86% of Eu Yan Sang from Righteous Crane Holding. Righteous Crane Holding is owned by a fund managed by Tower Capital Asia, a unit of Temasek Holdings and founding fa